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Abstract Phytotherapeutic pharmaceuticals and herbal
medicinal products with its roots in classical phytothera-
peutic medicine have a well-established role in otolaryngo-
logical therapy, especially for diseases of the upper airways
and acute and chronic infections. A thorough selection and
application could mean huge beneﬁt for the patient, in par-
ticularincaseswithcontraindications,chemo-andantibiotic
resistance or patient request. Besides, it might spare other
medications. Phytotherapeutic pharmaceuticals must fulﬁl
the same criteria of quality, effectiveness and harmlessness
of evidence-based medicine like chemical pharmaceuticals,
although they are often prescribed due toits well established
or traditional based use. This review focuses on phytother-
apeutic therapies well established within the European
Communityforotolaryngologicdiseasepatternsbyreferring
to clinical studies or meta-analysis.
Keywords Phytotherapy  Naturopathy  Essential oils 
Acute rhinosinusitis  Acute otitis media
Introduction
Henri Leclerc (1870–1955) introduced the terminology of
phytotherapy into medical science. Natural products were
used in non-scientiﬁc manner before. People experienced
natural products as being helpful for their health and
learned to treat illnesses disease-speciﬁc. Therefore, it is
appropriate to discuss phytotherapeutic and naturopathic
adjuvant therapies in a disease oriented manner. Phyto-
pharmaceuticals consist of a main ingredient that is
responsible for the main mechanism of efﬁcacy and of
auxiliary agents, backing agents (effecting pharmacoki-
netics) and structure stabilizing agents. Often phytothera-
peutic pharmaceuticals are composed of numerous herbal
products or agents increasing medical effectiveness.
Generally speaking, phytopharmaceuticals are not used in
emergency medicine and acute care medicine, but are indi-
catedindiseasesofmildtointermediateseverity,inparticular
in cases of functional or chronic diseases. Adjuvant or co-
therapy, relapse prevention, reconvalescence and unveriﬁed
disorders are other indications for phytopharmaceuticals.
In contrast to chemical pharmaceuticals, phytothera-
peutics possess a wider therapeutic range, lesser adverse
reactions and less interactions with other pharmaceuticals.
As well as in chemical pharmaceuticals, thoroughly un-
derdosage, false applications and application duration have
to be regarded and overestimation of effectiveness has to
be avoided. Administration form and usage have to be
tailored to the individual patient needs (Table 1). Conse-
quently, adequate diagnostic means must proceed the
administration of phytopharmaceuticals.
Evidence-based medicine has entered phytotherapeutic
medicine as well and therefore its beneﬁts and advantages
have been established in clinical studies and meta-analysis
in the last years. In addition, due to the long tradition of
phytotherapy individual-based and experienced-based
medicine provide the basis for consideration of off-label-
use in cases where clinical studies are missing.
Acute and chronic rhinosinusitis
In otolaryngology, phytopharmaceuticals which combine
secretolytic, mucolytic, mucous membrane detumescing,
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are classically used in diseases of the upper airways. Nose
douches or inhalations with Emser brine or chamomile
ﬂower solutions represent usually the basal treatment in
banal or allergic rhinitis. In addition, applied nasal sprays
with seawater and chamomile avoid privinism. Essential
oils of eucalyptus leaf and branch (Eucalyptus globulus, E.
polybractea or E. smithii, Myrtaceae), peppermint leaf
(Mentha piperita, Lamiaceae), mugo pine (Pinus mugo,
Pinaceae) have secretolytic and antimicrobial effects, but
should not be applied in infants due to the danger of lar-
yngo- or bronchospasm (Kratschmer reﬂex). Together with
its ingredients, menthol, camphor and 1,8-cineol they
depolarize the thermoreceptors by inhibition of the calcium
inﬂux (Table 2) and lead to a subjective improvement of
airﬂow although the nasal resistance is not decreased [1].
Systemic administered phytopharmaceuticals containing
essential oils like GeloMyrtol
 gastro-resistant capsules
(standardized to contain not less than 30 mg limonene,
30 mg cineol and 8 mg alpha-pinene, manufactured by G.
Pohl-Boskamp GmbH & Co KG, Hohenlockstadt, Ger-
many) have shown increase of the mucociliary secret
transport velocity by 28% and of the secretolysis by 30%
[2]. GeloMyrtol
 is administered in acute and chronic
rhinosinusitis and after operations of the paranasal sinuses
as well (Table 3)[ 3]. The combination herbal medicine
Sinupret
 contains powdered herbal extracts of European
elder ﬂower (Sambucus nigra, Caprifoliaceae), garden
sorrel herb (Rumex acetosa, Polygonaceae), cowslip ﬂower
(Primula veris, Primulaceae), European vervain herb
(Verbena ofﬁcinalis, Verbenaceae), gentian root (Gentiana
lutea, Gentianaceae) and liqueﬁes the nasal mucous and
secretions and acts antiphlogistic as well. A meta-analysis
has shown that alternate application of GeloMyrtol
 and
Sinupret
 has best beneﬁts in acute and chronic rhinosi-
nusitis [4] and can be used in pregnancy, too [5]. Besides
Sinupret
 and GeloMyrtol
 can be used in acute and
chronic bronchitis [6] and it could be shown that the efﬁ-
cacy of Sinupret
 is superior to ambroxol and n-acetyl-
cysteine [7–9]. It could be shown that Tesalin N
 ﬁlm
tablets (containing a CO2-extract, Ze 339, of purple but-
terbur leaf (Petasites hybridus, Asteraceae), manufactured
by Zeller Medical AG, Romanshorn, Switzerland) are as
effective as fexofenadin and cetirizin in allergic rhinitis
[10, 11]. A meta-analysis showed equivalent effectiveness
when compared with non-sedative antihistamines [12].
Acute and chronic laryngopharyngitis
About 50–70% of acute infections of the pharyngolaryn-
geal spaces are of viral pathogenesis [13–15]. Therapeutic
considerations of antibiotics with regards to microbial eti-
ology starting point and duration of application or cost-
effectiveness have been discussed extensively. Generally
speaking, antibiotics have to be applied, whenever com-
plications occur. Typically, gurgle solutions with sage leaf
(Salvia ofﬁcinalis, Lamiaceae), thyme herb (Thymus vul-
garis, Lamiaceae) or chamomile ﬂower (Matricaria recu-
tita, Asteraceae) are applied in acute laryngopharyngitis.
Imupret
 dragees or drops (a combination herbal medicine
Table 1 Mode of preparation and administration form of phytotherapeutics
Mode of preparation Administration form Therapeutical application and characterization
Aqueous extracts
Extracts with ethanol
(tincture, ﬂuid extracts)
Drops, inhalations, gargle solutions Contain about 20–60% alcohol
Extracts with wine Tonics, medicated wines Contain about 16% alcohol
Spissum extracts Baths, gels, soft gelatin capsules Baths are in particular useful in early infections and
should not be used when body temperature is increased
Alcoholic distillates Contain essential oils, e.g. spirit
of melissa
Contain 40–80% alcohol
Steam distillates Essential oils Most essential oils have to be diluted (e.g. in sunﬂower,
peanut, almond oil 1/9) to avoid mucosal irritation or
combined with a plant oil for skin preparations
Tea Infusion For small plant parts, thermolabile and volatile ingredients
Decoction For not easily dissoluble plant parts and ingredients
Maceration (cold preparation) Plant parts where hot preparation would damage
or release damaging ingredients
Juices Fresh-squeezed plant juices Contain four times more active ingredients than tea
Creams, ointments, gels Inunctions, fomentations Selection and application according to skin moisture
Dry preparations (shredded,
pulverized)
Tablets, dragees, pastilles, pellets,
capsules
For systemic application
390 Eur Arch Otorhinolaryngol (2012) 269:389–397
123manufactured by Bionorica AG, Neumarkt, Germany) can
be used in chronic tonsillitis, tracheitis or in adenoid
hyperplasia and acts antiphlogistic, astringent and immu-
nomodulating. It contains aqueous-alcoholic extracts of
marshmallow roots (Althaea ofﬁcinalis, Malvaceae),
chamomile ﬂower, oak bark (Quercus robur, Q. Petraea,
Q. pubescens, Fagaceae), English walnut leaves (Juglans
regia, Juglandaceae), dandelion herb (Taraxacum ofﬁci-
nale, Asteraceae), horsetail herb (Equisetum arvense,
Equisetaceae) and yarrow ﬂower (Achillea millefolium,
Asteraceae) [16]. Two important phytotherapeutics with
antimicrobial qualities are garden nasturtium haulm
(Tropaeolum majus, Tropaeolaceae) and horseradish root
(Armoracia rusticana, Brassicaceae) which contain mus-
tard oils that have antibacterial properties against gram-
positive and gramnegative strains, virostatic and
antimycotic effects and can be used when antibiotics
should be avoided. The combination herbal medicine An-
gocin
 (ﬁlm tablets, manufactured by REPHA GmbH Bi-
ologische Arzneimittel, Langenhagen, Germany) uses
synergistic effects of these two herbs. In particular, efﬁcacy
against Pseudomonas species has been proven and studies
showed equivalent efﬁcacy compared with standard anti-
biotics [17–19]. Willow bark (Salix purpurea, S. daphno-
ides, S. fragilis, Salicaceae) decreases the body temperature
directly due to its main ingredient salicin which in contrast
to acetylsalicylic acid (ASA) lacks the acetyl-group and
therefore has no adverse reactions in regards with stomach
mucosa and platelet aggregation. Standardized willow bark
extracts has comparable antiinﬂammatory activities as
higher doses of ASA and shows antinociceptive and
antipyretic effects [20]. Besides European elder berry
(Sambucus nigra, Caprifoliaceae) and lime ﬂower tea (Tilia
platyphyllos, T. cordata, T. vulgaris, Tiliaceae) are often
used to reduce body temperature and it could be shown that
elder berry preparations reduce symptoms and illness
duration 4 days faster when compared with placebo syrup
in inﬂuenza A and B infections [21]. Marigold (Calendula
ofﬁcinalis, Asteraceae) and pelargonium root (Pelargonium
sidoides, Geraniaceae) are successfully used in the treat-
ment of upper infections of the respiratory tract and for
acute and chronic tonsillitis as well [22, 23]. They have
antibacterial, antiviral and secretolytic functions, but have
to be applied in tonsillitis off-label as clinical data are not
sufﬁcient [24, 25].
Cough
Acute and chronic cough impair the general condition and
should often be avoided after chirurgical interventions.
Suppressing the need to cough can be achieved by physical
and pharmacological measures. Main physical supporting
measures include intake of ﬂuids by drinking, inhalation
and air humidiﬁcation. A productive cough is often pre-
ceded by a dry and painful cough. Different phytothera-
peutics have to be used in these disease stadiums. Opium
alkaloids like codeine or noscapine have a direct antitus-
sive effect on the CNS cough center in the medulla
oblongata and the sensory nerves in the lower airways.
They are applied in the phase of dry cough and mainly
administered at night and only for a short time. Alterna-
tively, phytopharmaceuticals that possess an antitussive
Table 2 Phytotherapeutic therapy of upper airway and deglutition tract infections
Main mode of action Phytotherapeutics Characterization
Antiphlogistic Chamomile ﬂower, myrtle, thyme herb, sage
leaf
a-Bisabolol and chamazulene in camomile
inhibit the cyclooxygenase and lipoxygenase
of arachidonic acid cascade
Antitussive-mucous releasing Marshmallow leaf or root, ribwort plantain
leaf,
iceland moss thallus
Contain polysaccharides which swell with water
Antitussive-mucolytic
(saponins)
Cowslip ﬂower, thyme herb, english ivy leaf,
mullein ﬂower
Decrease mucous viscosity by decreasing the surface
tension of water
Respiratory relieving,
secretolytic
Mint oils (eucalyptus leaf and branch,
peppermint leaf, mugo pine)
Central inhibitory effect by thermosensitive nerves
Cave: Kratschmer reﬂex in children
Menthol, camphor, 1,8-cineol Depolarization of thermoreceptors by inhibition of calcium
inﬂux
Antimicrobial Garden nasturtium haulm, horseradish root Contains mustard oils
Antipyretic Lime ﬂower, willow bark, european elder
berry
The lacking acetyl group in salicin in elder avoids
side effects of ASA
Immunomodulating Echinacea root, chamomile ﬂower Stimulation of the unspeciﬁc cellular and humoral immune
response
Cave: application duration, autoimmune and
systemic diseases
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123Table 3 Discussed phytotherapeutic pharmaceuticals and their indication, administration form and dose
Phytotherapeutic
pharmaceutical
Indication Administration
form
Dose
Angocin
, REPHA GmbH
Biologische
Arzneimittel,
Langenhagen, Germany
Phytotherapeutic pharmaceutical with
antibacterial properties against
grampositive and gramnegative strains,
virostatic and antimycotic effects
Film tablet 4–5 tablets 3–5 times per day, children
(4–8 years) 2–3 tablets 3–5 times per day
Acute infections (e.g. acute
pharyngotonsillitis, acute laryngitis, acute
sinusitis)
Bronchipret
, Bionorica
AG, Neumarkt, Germany
Acute and chronic bronchitis Drops, syrup or
ﬁlm tablet
Drops: 40 drops 4 times per day, adolescents
(12–18 years) 28 drops 4 times per day,
children (6–11 years) 20 drops 4 times per
day
Expectorant
Syrup: 5.4 ml 3 times per day, babies (-12
month) 1.1 ml 3 times per day, infants
(-2 years) 2.2 ml 3 times per day, children
(-6 years) 3.2 ml 3 times per day,
children (-12 years) 4.3 ml 3 times per
day
Tablets: 1 tablet 3 times per day
Contramutan
 N,
manufactured by A.
Nettermann & Cie.
GmbH, Cologne,
Germany
Acute infectious of the upper airways
(e.g. acute laryngopharyngitis)
Drops, syrup or
tablet
Drops: 5–10 drops up to 12 times per day,
children (6–12 years) 4–7 dops up to 12
times per day, children (1–6 years) 3-5
drops up to 12 times per day; after symptom
relief intake is reduced to 3 times per day
Syrup: 15 ml every hour, children 5 ml every
hour; after symptom relief intake is reduced
to 3 times per day
Tablets: 1 tablet up to 12 times per day,
children 1 tablet up to 6 times per day; after
symptom relief intake is reduced to 1–3
times per day
Equisil
 N, Dr. Gustav
Klein GmbH & Co KG,
Zell am Hamersbach,
Germany
Intermediate cough state (productive and dry) Syrup 2.5 ml 3 times per day
Esberitox
, Schaper &
Bruemmer GmbH & Co
KG, Salzgitter, Germany
Acute infectious of the upper airways
(e.g. acute laryngopharyngitis)
Drops, tablet 50 drops or 3 tablets 3 times per day, babies
10 drops or 1 tablet once per day, children
(-6 years) 15 drops or 1–2 tablets twice
per day, children (-12 years) 25 drops or 2
tablets twice per day
GeloMyrtol
 forte, G. Pohl
Boskamp GmbH & Co
KG, Hohenlockstadt,
Germany
Acute and chronic rhinosinusitis Gastro-resistant
capsule
1 capsule 3–4 times per day for acute
infections, 1 capsule twice for chronic
infections
Acute and chronic bronchitis
Postoperative convalescence
Pregnancy
Imupret
, Bionorica AG,
Neumarkt, Germany
Chronic tonsillitis, tracheitis, adenoid
hyperplasia
Dragee or drops 2 dragees or 25 drops 5–6 times per day,
children (-12 years) 1 dragee or 15 drops
once per day, babies and infants 5–10 drops
5–6 times per day; after symptom relief
intake is reduced to 3 times per day for
7 days
Lomaherpan
,
Lomapharm Rudolf
Lohmann GmbH KG,
Emmerthal, Germany
Skin or mucosa infections with herpes
simplex virus
Cream 10–20 mg per cm
2 2–4 times per day
Otikon Otic
 solution,
Healthy-On Ltd., Petach-
Tikva, Israel
Acute otitis media Ear drops 5 drops 3 times per day
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123and abirritative effect by contain polysaccharides that swell
with water and produce a mucous layer inhibiting the
hyperactive ciliary activity can be applied in dry cough.
These phytopharmaceuticals usually contain marshmallow
leaf or root (Althaea ofﬁcinalis, Malvaceae), ribwort
plantain leaf (Plantago lanceolota, Plantaginaceae) or
iceland moss thallus (Cetraria islandica, Parmeliaceae). A
productive cough should be treated with expectorations
like cowslip ﬂower (Primula veris, Primulaceae), thyme
herb, English ivy leaf (Hedera helix, Araliaceae) or mullein
ﬂower (Verbascum densiﬂorum, V. phlomoides, V. thapsus)
[26]. Syrup can be used for children [27]. These plants
contain saponins which decrease mucous viscosity by
decreasing the surface tension of water, increase ciliary
activity and possess an antiphlogistic and bronchospas-
molytic effect [28]. A combination of both mucous-
releasing and secretolytic acting ingredients can be used in
an intermediate cough state, e.g. Equisil
 N Syrup (con-
taining extracts of cowslip ﬂower, mullein ﬂower, thyme
herb and ribwort plantain leaf, manufactured by Dr. Gustav
Klein GmbH & Co KG, Zell am Hamersbach, Germany).
Various studies have shown similar or superior effects of
phytopharmaceutical expectorations compared to acetyl-
cysteine or ambroxol. Prospan
, a dried ivy leaf extract
(drops, liquid, syrup or tablets, manufactured by Engelhard
Arzneimittel, Niederdorfelden, Germany), showed superi-
ority to acetylcysteine [29] and Bronchipret
 ﬁlm tablets
(dried alcoholic extracts of primula root and thyme herb,
manufactured by Bionorica AG, Neumarkt, Germany)
showed equivalency to ambroxol and n-acetylcysteine [30,
31]. In addition, essential mint oils due to its secretolytic
effects can be inuncted or inhaled. They are well reab-
sorbed by the skin, e.g. as warm thorax compresses in
pseudocroup. Menthol, camphor, 1,8-cineol activate the
cold receptors in the larynx and have an antitussive and
negative inspiratory effect [32].
Herpese simplex infection and stomatitis
It could be shown that lomaherpan
 cream (manufactured
by Rudolf Lohmann GmbH KG, Emmerthal, Germany)
which contains dried extract of lemon balm leaf (Melissa
ofﬁcinalis, Lamiaceae) can be used for prophylaxis and is
as effective as acyclovir when administered in the ﬁrst 8 h
in herpes simplex infections [33]. Besides, healing is faster
and recurrences are reduced [34, 35]. Another study
showed that rhubarb-sage cream is as effective as acyclovir
[36]. Other therapeutics and preparations that have been
effective in herpes simplex infections are propolis [37],
ozonated olive oil or essential oils with thyme herb,
chamomile ﬂower, ginger root, peppermint leaf, eucalyptus
leaf and tea tree foliage (Melaleuca alternifolia, M. dissi-
tiﬂora, M. linariifolia, Myrtaceae) [38–40]. Topical medi-
cations, such as mouth-washes and topical corticosteroids
Table 3 continued
Phytotherapeutic
pharmaceutical
Indication Administration
form
Dose
Prospan
, Engelhard
Arzneimittel,
Niederdorfelden,
Germany
Productive cough Drops, liquid,
syrup,
suppository,
ﬁzzy tablet or
ﬁlm tablet
Drops: 24 drops 3 times per day, children
(4–10 years) 16 drops 3 times per day,
children (1-year) 12 drops 3 times per day
Expectorant
Liquid: 5 ml 3 times per day
Syrup: 5–7.5 ml 3 times per day, children
(6–9 years) 5 ml 3 times per day, children
(1–5 years) 2.5 ml 3 times per day,
children (-12 month) 1.5 ml twice per day
Suppositories: school children 1 supp. 3
times per day, babies and infants 1 supp.
twice per day
Brausetabletten: 1 tablet twice per day,
children (4–12 years)  tablet 3 times per
day
Film tablets: 2 tablets 3 times per day
Sinupret
, Bionorica AG,
Neumarkt, Germany
Acute and chronic rhinosinusitis, Drops, liquitab
,
dragee
50 drops, 2 dragees or 2 liquitabs three times
per day, children (6–12 years) 25 drops, 1
dragee or 1 liquitab per day, children
(2–6 years) 15 drops per day
Acute and chronic bronchitis
Postoperative convalescence
Pregnancy
Tesalin
 N, Zeller Medical
AG, Romanshorn,
Switzerland
Allergic rhinitis Film tablets 1 tablet 2–3 times per day
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123can achieve the primary goal to reduce pain and to improve
healing time but do not improve recurrence or remission
rate in recurrent aphthous stomatitis. It could be shown that
myrtle (Myrtus communis, Myrtaceae) reduces ulcer size,
pain severity, erythema and exudation level **in recurrent
aphthous stomatitis [41], and a daily intake of 500 mg bee
propolis could reduce the outbreaks in recurrent aphthous
stomatitis [42]. Candidiasis or thrush can be effectively
treated with solutions or tinctures of chamomile ﬂower,
myrtle, sage leaf, or thyme herb [43]. Besides, essential oil
of thyme herb potentiates the antifungal effect of ampho-
tericin B in culture [44]. In addition, maloudor in cancer
patients improves signiﬁcantly and ulcer healing beneﬁts
after essential oil application (in this study an essential oil
mix based on eucalyptus was applied twice daily) [45].
Besides, astringencies who have antiinﬂammatory, weak
antiseptic effects and increase tissue repair like arnica
ﬂower (Arnica montana, Asteraceae), mulberry leaves
(Morus alba, Moraceae) and silverweed (Argentina anse-
rina, Rosaceae) are used in stomatitis, as well as aromatica
(essential oil drugs) with its antiphlogistic and antimicro-
bial effects like clove ﬂower bud (Syzygium aromaticum,
Myrtaceae), calendula ﬂower or rose blossom (Rosa spp.,
Rosaceae) [46].
Acute otitis media
About 50% of all acute middle ear infections are of viral
pathogenesis [47]. Antibiotic usage in uncomplicated acute
otitis media in children has been discussed controversial
recently [48, 49]. It has been advocated that a watchful
waiting period of 2–3 days is adequate before administer-
ing antibiotics [50]. However, antibiotics have to be
applied whenever complications occur. To reduce the pain,
a hot chamber that can be simple made by hot washcloth
and a bathing cap is often very helpful. The American
Academy of Otolaryngology-Head and Neck Surgery
guidelines recommend topical medications as the ﬁrst line
of treatment for ear pain in the absence of systemic
infection or serious underlying disease. There is some
evidence that in the management of ear pain topical com-
bination herbal medicines (e.g. Otikon otic solution con-
taining extracts of garlic bulb, mullein ﬂower, calendula
ﬂower and St. John’s wort herb in olive oil, manufactured
by Healthy-On Ltd., Petach-Tikva, Israel) are as effective
as oral amoxicillin and topical anaesthetics due to its
antimicrobial, antiinﬂammatory, immunostimulating
effects and good penetration through the tympanic mem-
brane [51, 52]. Generally speaking, the dosage for phyto-
therapeutic drugs in children can be estimated for children
under 4 years of age with 1/3 of the dosage for adults,
children to 10 years take 1/2 and children to 16 years take
2/3 of the adult dosage.
Otitis externa diffusa
Infections of the outer ear canal are often only controlled
when systemically and locally treated with longer appli-
cation duration at the same time. First, cerumen and
detritus have to be sucked from the outer ear canal to avoid
a growing medium. Phytopharmaceuticals can be of adju-
vant beneﬁt for these patients often suffering from systemic
diseases as well. Above-mentioned antiviral, antimycotic
and antibacterial tinctures, drops or solutions are very
useful in otitis externa as well, e.g. otikon ear drops,
essential oil drugs, melissae or myrtle tinctures (Loma-
herpan
, lomastatin
).
Reﬂux disease
The importance of gastroesophageal reﬂux in the aetio-
pathogenesis for various diseases of the upper airways and
deglutition pathways, including cancerogenesis, is well
known in otolaryngology. Reﬂux disease with a prevalence
of up to 20% is a common symptom in western civiliza-
tions and can be the reason for other symptoms as globus
pharyngis, postnasal drip, cough or halitosis [53]. Besides
gastroesophageal reﬂux affects wound healing negatively.
A tea spoon of healing earth (e.g. Luvos
, Heilerde-
Gesellschaft Luvos Just GmbH & Co KG) equating 6.5 g
has an acid-binding capacity of 25 mVal that is recom-
mended for an antacidum from the German Federal Insti-
tute for Drugs and Medical Devices (BfArM). Asian
ginseng root (Panax ginseng, Araliaceae) can be used in
chronic erosive esophagitis [54] and possesses anticancer-
ogenic effects [55].
Wound care
Acute and chronic wounds beneﬁt from adjuvant phyto-
therapeutic and naturopathic care, although further research
has to be done in this ﬁeld. In vitro studies have shown the
stimulation of keratinocytes cell proliferation of bee
propolis in wound healing [56]. Meta-analyses have shown
that medical grade honey (Medihoney, standardized anti-
bacterial honey) is suitable as alternative for wound heal-
ing, burns, oral and external surgical wounds, various skin
conditions and in the cancer setting, e.g. applied for radi-
ation-induced mucositis, radiotherapy-induced skin reac-
tions, hand and foot skin reactions in chemotherapy [57–
59]. Ozone or ozonated olive oil application has been used
for many years as a method ancillary to basic treatment in
acute or chronic wounds, especially in those cases in which
traditional treatment methods do not give satisfactory
results, e.g. skin loss in non-healing wounds, ulcers, pres-
sure sores, ﬁstulae, etc. [60–63]. Besides, essential oils
represent a cheap and antiseptic effective treatment option
394 Eur Arch Otorhinolaryngol (2012) 269:389–397
123for antibiotic-resistant strains of MRSA and antimycotic-
resistant Candida species [64]. Calendula ﬂower has anti-
phlogistic, immunostimulating, cytotoxic, antimicrobial,
antiedematous, lymphagogue, phagocytosis and granulo-
cytosis increasing effects and is successfully applied topi-
cally and systemic in the prevention and treatment of
radiation dermatitis, venous ulcers and postoperative
wounds [65–69].
Immunomodulation and immunostimulation
The terminology of immunomodulation should be pre-
ferred to immunostimulation as many phytotherapeutics
used for a longer time or used in systemic and autoimmune
diseases can lead to immunodepression. Therefore, cone-
ﬂower root (Echinacea spec., Asteraceae) should not be
applied longer than 8 weeks in adults and 2 weeks in
children at a stretch. Echinacea and combination medicines
(e.g. Esberitox
, manufactured by Schaper & Bruemmer
GmbH & Co KG, Salzgitter, Germany or Contramutan
N,
manufactured by A. Nettermann & Cie. GmbH, Cologne,
Germany) can be used in all acute infections and is helpful
in acute laryngopharyngitis, in particular [70, 71]. It
enhances cell-mediated immunity by stimulation of mac-
rophages, natural killer cells and granulocytes as well as
humoral immunity through monokines, interferons and the
complement system. Further herbs used for immunomod-
ulating combination herbal medicines or single prepara-
tions are thuja herb (Thuja occidentalis, Cupressaceae),
hemp agrimony (Eupatorium cannabinum, Asteraceae),
boneset (Eupatorium perfoliatum, Asteraceae), wild indigo
root (Baptisia tintoria, Fabaceae), lime ﬂower, European
elder berry, chamomile ﬂower, meadowsweet herb (Fili-
pendula ulmaria, Rosaceae) and pelargonium root (Pelar-
gonium sidoides, Geraniaceae). Besides, it could be shown
that Asian ginseng root (Panax ginseng, Araliaceae)
accelerates reconvalescence, body weight, leukocytes and
serum protein after operations and radiotherapy [72].
Vertigo and kinetosis
Scopoderm is a transdermal patch contain pure scopol-
amine, an alkaloid of belladonna leaves. It should be
administered 4–6 h before the start of a journey. Equivalent
effects for motion sickness (kinetosis) have been shown for
ginger rhizome (zingiber ofﬁcinale, Zingiberaceae) [73,
74]. Besides, ginger is well known for nausea and vomiting
in pregnancy and postoperative care. Numerous trials,
reviews and meta-analyses have shown equivalent efﬁcacy
when compared with hydrochloride (vitamin B6) and
metoclopramide [75–80]. Extracts of Gingko leaves
(Gingko biloba, Gingkoaceae) have positive effects on the
microcirculation and can be effectively used in long-time
therapy for vestibular vertigo [81, 82].
Conclusion
Phytotherapeutic pharmaceuticals and herbal medicinal
products with its roots in classical phytotherapeutic medi-
cine have a well-established role in otolaryngological
therapy within the European Community. A thorough
selection and application can mean huge beneﬁt for the
patient, in particular in cases with contraindications,
chemo- and antibiotic resistance or patient request. In
complicated cases of upper airway or ear infections
chemical antibiotics are indicated, but phytopharmaceuti-
cals can be of additive value. In cases, where clinical
studies and meta-analysis are missing, the long tradition of
individual-based and experienced-based medicine provide
the basis for therapeutical consideration.
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